On Thursday, Shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), dropped -4.89% to $8.75.
Achillion Pharmaceuticals, declared that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at two forthcoming investor conferences:
- Deutsche Bank 40th Annual Health Care Conference on Thursday, May 7, 2015 at 8:00 a.m. ET at The Intercontinental Hotel in Boston, MA; and
- UBS Global Healthcare Conference on Monday, May 18, 2015 at 11:30 a.m. ET at The Sheraton New York Hotel in New York, NY.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.
Shares of Unilife Corporation (NASDAQ:UNIS), declined -4.83% to $3.35, during its last trading session.
Unilife Corporation, declared that it intends to release its financial results for the third quarter of fiscal 2015 ended March 31, 2015 after-market trading ends on Monday, May 11, 2015.
Administration has planned a conference call for 4:30 p.m. EDT on Monday, May 11, 2015 (Tuesday, May 12, 2015 at 6:30 a.m. AEST).
Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod.
At the end of Thursday’s trade, Shares of Zimmer Holdings, Inc. (NYSE:ZMH), dwindled -4.77% to $109.84.
Zimmer Holdings, stated financial results for the quarter ended March 31, 2015. The Company stated first quarter net sales of $1.13 billion, a decrease of 2.3% stated and an enhance of 4.5% constant currency contrast to the first quarter of 2014. Diluted earnings per share for the quarter were $1.02 stated and $1.58 adjusted, a decrease of 1.3% adjusted from the preceding year period.
Net earnings for the first quarter were $177.1 million on a stated basis and $272.8 million on an adjusted basis, a decrease of 0.6% adjusted from the preceding year period. Operating cash flow for the first quarter was $73.0 million, inclusive of a payment of $97.6 million to settle a pre-issuance hedge contract associated with the Company’s recent senior notes offering.
Also in the quarter, the Company paid $37.3 million in dividends and declared a first quarter dividend of $0.22 per share, consistent with the dividend declared for the preceding year period.
Zimmer Holdings, Inc., together with its auxiliaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific.
Finally, ARMOUR Residential REIT, Inc. (NYSE:ARR), ended its last trade with -4.76% loss, and closed at $3, hitting its lowest level.
ARMOUR Residential, declared financial results for the quarter ended March 31, 2015.
Q1 2015 Highlights and Financial Information
- Core Income and estimated taxable Real Estate Investment Trust (“REIT”) income of about $33.5 million or $0.08 per Common share, which represents a 7.67% return on stockholders’ equity at the starting of the quarter
- Q1 2015 Generally Accepted Accounting Principles (“GAAP”) net loss of about $(125.5) million or $(0.37) per Common share
- Stockholders’ equity as of March 31, 2015, was about $1.66 billion or $4.14 per Common share
- March 31, 2015 “leverage” (debt to stockholders’ equity) and “hedge” (interest rate hedges to debt) ratios were 8.39 to 1 and 86.6%, respectively
- Liquidity as of March 31, 2015, comprising of cash and unpledged securities, of about $897.6 million
- Q1 2015 average yield on assets of 2.72% and average net interest margin of 1.20%
- Q1 2015 annualized average principal repayment rate (CPR) of 6.70%.
ARMOUR Residential REIT, Inc. invests in and manages a portfolio of residential mortgage backed securities in the United States. The company is managed by ARMOUR Capital Administration LP.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
